Quotes 5-day view  End-of-day quote Deutsche Boerse AG | |
|
| 05/17/2013 |
05/20/2013 |
05/21/2013 |
05/22/2013 |
05/23/2013 |
Date |
| 14.851(c) |
14.675(c) |
14.48(c) |
14.803(c) |
13.752 |
Last |
| 0 |
0 |
0 |
50 |
0 |
Volume |
| -0.22% |
-1.19% |
-1.33% |
+2.23% |
-7.10% |
Change |
| |
|
|
|
|
Surperformance© rating of DAIICHI SANKYO COMPANY, LI
| Trading Rating : |
|
Investor Rating : |
|
| |
|
| Chart DAIICHI SANKYO COMPANY, LI |
|
|
Duration :
Period :
|
| |
|
|
|
|
|
Sales 2014 |
1 042 217 M |
|
EBIT 2014 |
- |
|
Net income 2014 |
65 704 M |
|
Finance 2014 |
136 293 M |
|
Yield 2014 |
3,13% |
|
|
Sales 2015 |
1 061 350 M |
|
EBIT 2015 |
- |
|
Net income 2015 |
67 735 M |
|
Finance 2015 |
172 262 M |
|
Yield 2015 |
3,15% |
|
|
PER 2014 |
20,24 |
|
PER 2015 |
19,44 |
|
EV / Sales 2014
|
1,19x |
|
EV / Sales 2015
|
1,14x |
|
Capitalization
|
1 381 176 M |
|
| |
|
| Latest news on DAIICHI SANKYO COMPANY, LI |
|
| 1d ago | | DAIICHI SANKYO COMPANY, LIMITED: Ranbaxy Announces Improved Business Standards .. |
| 05/13 | DJ | Astellas, Daiichi Sankyo See New Drugs Propelling Growth |
| 05/13 | | DAIICHI SANKYO COMPANY, LIMITED: Daiichi Sankyo Announces New Executive Candida.. |
| 05/13 | | DAIICHI SANKYO COMPANY, LIMITED: Differences Between Consolidated Forecasts and.. |
| 05/08 | | DAIICHI SANKYO COMPANY, LIMITED: Ranbaxy Q1 CY 2013 Sales Rs.24,398 Mn. Base bu.. |
| 04/26 | | DAIICHI SANKYO COMPANY, LIMITED: Daiichi Sankyo Submits Application to Delist S.. |
| 04/24 | | DAIICHI SANKYO COMPANY, LIMITED: Daiichi Sankyo Enrolls First Patient in Nimotu.. |
| 04/24 | | DAIICHI SANKYO COMPANY, LIMITED: About the News Report |
| 04/21 | | DAIICHI SANKYO COMPANY, LIMITED: Daiichi Sankyo Launches Silodosin for the Trea.. |
| 04/17 | | DAIICHI SANKYO COMPANY, LIMITED: Daiichi Sankyo and Ranbaxy launch hybrid busin.. |
| 04/08 | | DAIICHI SANKYO COMPANY, LIMITED: Daiichi Sankyo Participates in Establishment o.. |
| 04/02 | | Big Pharma down, not out, after Indian patent blow |
| |
|
| Forum DAIICHI SANKYO COMPANY, LI |
|
|
| |
|
|
|
|
